Briviact

Medicinal product

(Invented) name

Briviact

Active substance (s)

Brivaracetamas

Strength

25 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N03AX23, Brivaracetam

Marketing authorisation holder

UCB Pharma S.A., Belgija

Date of authorisation

2016-01-14

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Brivaracetamas	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
65026	79522	1079522	lizdinė plokštelė	N14		Receptinis	EU/1/15/1073/005	Netiekiama	-	-	No	-	-
65027	79523	1079523	lizdinė plokštelė	N56		Receptinis	EU/1/15/1073/006	Netiekiama	-	-	No	-	-
65028	79524	1079524	dalomoji lizdinė plokštelė	N100x1		Receptinis	EU/1/15/1073/007	Netiekiama	-	-	No	-	-
65029	79525	1079525	lizdinė plokštelė	N168 (3x56) (sudėtinė)		Receptinis	EU/1/15/1073/008	Netiekiama	-	-	No	-	-
65981	80495	1080495	dalomoji lizdinė plokštelė	N14x1		Receptinis	EU/1/15/1073/024	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2016-01-14	Registruotas